A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone

Purpose: The aim of this study was to identify a noninvasive urinary marker for prostate cancer (PCa) diagnosis and to validate the clinical performance of this novel urinary mRNA signature using the droplet digital polymerase chain reaction (ddPCR) approach. Materials and Methods: A gene expression...

Full description

Bibliographic Details
Main Authors: Ho Won Kang, Hee Youn Lee, Young Joon Byun, Pildu Jeong, Jin Sun Yoon, Dong Ho Kim, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Seok Joong Yun, Wun-Jae Kim
Format: Article
Language:English
Published: Korean Urological Association 2020-07-01
Series:Investigative and Clinical Urology
Subjects:
diagnosis
microarray analysis
prostatic neoplasms
urine
Online Access:https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-411.pdf

Internet

https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-411.pdf

Similar Items